Reinnervation of post-arthritic joints in the rat

Clinical and Experimental Rheumatology

Volumn 14, Issue 1, 1996, Pages 43-51

  Pereira Da Silva, J A ^a,b   Fonseca, J E ^a,b   Graca L ^a   Moita, L ^a   Carmo Fonseca, M ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Arthritis; Nerves; Neuropeptides

Indexed keywords

BIOLOGICAL MARKER; NEUROPEPTIDE;

ACUTE DISEASE; ANIMAL; ANKLE; ARTHRITIS; ARTICLE; FEMALE; FLUORESCENCE MICROSCOPY; INNERVATION; KNEE; METABOLISM; NERVE FIBER; NERVE REGENERATION; PATHOLOGY; PHYSIOLOGY; RAT; WISTAR RAT; ANIMAL EXPERIMENT; CONTROLLED STUDY; PRIORITY JOURNAL; REINNERVATION;

ACUTE DISEASE; ANIMALS; ANKLE JOINT; ARTHRITIS, EXPERIMENTAL; BIOLOGICAL MARKERS; FEMALE; KNEE JOINT; MICROSCOPY, FLUORESCENCE; NERVE FIBERS; NERVE REGENERATION; NEUROPEPTIDES; RATS; RATS, WISTAR;

EID: 0029878532     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. LEVINE JD, COLLIER DH, BASBAUM AJ, MOSKOWITZ MA, HELMS CA: Hypothesis: The nervous system may contribute to the pathophysiology of rheumatoid arthritis. J Rheumatol 1985; 12: 406-11.
2. THOMPSON M, BYWATERS EGL: Unilateral rheumatoid arthritis following hemiplegia. Ann Rheum Dis 1962; 21: 370-7.
3. GLICK EN: Asymetrical rheumatoid arthritis after poliomyelitis. Br Med J 1967; 3: 26-8.
4. HAMMONDEH M, KHAN MA, KUSHNER I: Unilateral rheumatoid arthritis. Arthritis Rheum 1981; 24: 1218.
5. BAKER GHB: Life events before the onset of rheumatoid arthritis. Psyckoter Psychosom 1982; 38: 173-7.
6. BENNET PH, SCOTT JT: Autonomie neuropathy in rheumatoid arthritis. Ann Rheum Dis 1965; 24: 161-8.
7. EDMONDS ME, JONES TC, SAUNDERS WA, STURROCK RD: Autonomic neuropathy in rheumatoid arthritis. Br Med J 1979; 2: 173-5.
8. LEDEN I, ERIKSON A, LIEJA B, STURFELT G, SUNDKUIST G: Autonomic nerve function in rheumatoid arthritis of varying severity. Scand J Rheumatol 1983; 12: 166.
9. DUCLA SOARES J, FERREIRA M, POVOA P, PEREIRA DA SILVA JA, SANTOS MJ, PALMA CARLOS AG: Avaliação funcional do sistema nervoso autónomo na Artrite Reumatöide. (Abstract in English) Acta Médica Portuguesa 1993; 6: 245-8.
10. LEVINE JD, CLARK R, DEVOR M, HELMS C, MOSKOWITZ MA, BASBAUM AI: Intraneuronal substance P contributes to the severity of experimental arthritis. Science 1984; 226: 547-9.
11. LEVINE JD, DARDICK SJ, RAIZEN MS, HELMS C, BASBAUM AI: Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J Neurosci 1986; 6: 3423-9.
12. LEVINE JD, GOETZE EJ, BASBAUM AI: Contribution of the nervous system to the pathophysiology of rheumatoid arthritis and other polyarthritis. Rheum Dis Clin North Am 1987; 13: 369-83.
13. PITCHFORD S: Contribution of the nervous system to the pathophysiology of arthritis. In: Conference Documentation of Neuroimmune Interactions. New Approaches to the Immunological and Neurological Basis of Allergy and Autoimmune Disease. London, EBC Technical Services, 1988: 2-13.
14. GAMSE R, HOLZER P, LEMBECK F: Decrease of substance P in primary afferent neurones and impairment of neurogenic plasma extravasion by capsaicin. Br J Pharmacol 1980; 68: 207-13.
15. GAMSE R, LACKNER D, GAMSE G, LEEMAN SE: Effect of capsaicin pretreatment on capsaicin evoked release of immunoreactive somatostatin and substance P from primary sensory neurons. Naunyn Schmiedebergs Arch Pharmacol 1981; 316: 38.
16. GRONBLAD M, KONTTINEN YT, KORKALA O, LIESI P, HUKKANEN M, POLAK JM: Neuropeptides in synovium of patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 1988; 15: 1807-1810.
17. MAP PI, KIDD BL, GIBSON SJ, TERRY JM, REVELL PA, IBRAHIM NB, BLAKE DR, POLAK JM: Substance P, calcitonin gene-related peptide and c-flanking peptide of neuropeptide Y-immunoreactive fibers are present in normal synovium but depleted in patients with rheumatoid arthritis. Neurosci 1990; 37: 143-53.
18. PEREIRA DA SILVA JA, CARMO-FONSECA M: Peptide containing nerves in human synovium: immunohistochemical evidence for decreased innervation in rheumatoid arthritis. J Rheumatol 1990; 17: 1592-9.
19. KONTTINEN YT, REES R, HUKKANEN M, GRONBLAD M, TOLVANEN E, GIBSON SJ, POLAK JM, BREWERTON DA: Nerves in inflammatory synovium: immunohistochemical observations on the adjuvant arthritic rat model. J Rheumatol 1990; 17: 1586-91.
20. LEMBECK F, GAMSE R, JUAN H: Substance P and sensory nerve endings. In: VON EULER VS, PERNOW B (Eds.): Substance P, 37th Noble Symposium, Stockholm, 1976. New York: Raven Press, 1977: 169.
21. BAR-SHAVIT Z, GOLDMAN R, STABINSKY Y, GOTTLIEB P, FRIDKIN M, TEICHBERG VI, BLUMBERG S: Enhancement of phagocytosisa newly found activity of substance P residing in its N-terminal tetrapeptide sequence. Biochem Biophys Res Commun 1980; 94: 1445-51.
22. FOREMAN JC, JORDAN CC, PIOTROWSKY W: Interaction of neurotensin with the substance P receptor mediating histamine release from rat mast cells and the flare in human skin. Br J Pharmacol 1992; 77: 531-9.
23. PAYAN DG, GOETZ EJ: Modulation of lymphocyte function by sensory neuropeptides. J Immunol 1985; 135: 783-6.
24. STANISZ AM, BEFUS D, BIENENSTOCK J: Differential effects of vasoactive intestinal peptide, substance P and somatostatin on immunoglobulin synthesis and proliferation by lymphocytes from Peyer's patches, mesenteric lymph nodes and spleen. J Immunol 1986; 136: 152-6.
25. PAYAN DG, MCGILLES JP, GOETZ EJ: Neuroimmunology. In: DICKSON FJ, AMSTEN KF, HOOD L et al. (Eds.): Advances in Immunology. Orlando: Academic Press, 1986; 39: 299-323.
26. WIENSENFELD-HALLIN Z, HOKFEET T, LUNDBERG JM, FORSSMAN WG, REINECKE M, TSCHOPP FA, FISCHER JA: Immunoreactive calcitonin gene-related peptide and substance-P coexist in sensory neurons in spinal cord and interact in spinal behavioral responses of the rat. Neurosci Lett 1984; 52: 199-204.
27. FISCHER J, FORSMAN WG, HOKFELT T, LUNDBERG JM, REINECKE M, TSCHOPP FA, WIESENFELD-HALLIN Z: Immunoreactive calcitonin gene-related peptide and substance P: Coexistence in sensory neurons and behavioral interaction after intrathecal administration in the rat. J Physiol 1985; 362: 29P.
28. BUCK SH, WALSH JH, YAMAMURA HT, BURKS TF: Neuropeptides in sensory neurons. Life Sci 1982; 30: 1857-66.
29. LEEMAN SE, GAMSE R: Substance P in sensory neurons. Trends Pharmacol Sci 1981; 2: 119-21.
30. LUNDBERG JM, FRANCO-CERECEDA A, HUA X, HOKFELT T, FISCHER JA: Coexistence of substance P and calcitonin gene-reiated peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin. Eur J Pharmacol 1985; 108: 315-9.
31. GULBENKIAN S, MERIGHI A, WHARTON J, VARNDELL IM, POLAK JM: Ultrastructural evidence for the coexistence of CGRP and substance P in secretory vescicles of peripheral nerves in the guinea pig. J Neurocytol 1986; 15: 535-42.
32. LUNDBERG JM, TERENIUS L, HOKFELT T, MARTLING CR, TATEMOTO K, MUTT V, POLAK J, BLOOM S, GOLDSTEIN M: Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand 1982; 116: 477-80.
33. EHBLAD E, EDVISSON L, WAHLESTEDT C, UDDMAN R, HAKANSON R, SUNDLER F: Neuropeptide Y co-exists and cooperates with noradrenaline in perivascular nerve fibers. Reg Peptides 1984; 8: 225-35.
34. WAHLESTED C, EDVINSSON L, EKBLAD E, HAKANSSON R: Neuropeptide Y potentiates noradrenaline evoked vasoconstriction: mode of action. J Pharmacol Exp Ther 1985; 106: 577-83.
35. LINDE B, CHISHOLM G, ROSELL S: The influence of sympathetic activity and histamine on the blood tissue exchange of solutes in canine adipose tissue. Acta Physiol Scand 1974; 92: 144-55.
36. LAM FY, FERRELL WR: Acute inflammation in the rat knee joint attenuates sympathetic vasoconstriction but enhances neuropeptide mediated vasodilation assessed by laser Doppler perfusion imaging. Neurosci 1993; 52: 443-9.
37. ENGEL D: The influence of the sympathetic nervous system on capillary permeability. J Physiol (London) 1941; 99: 161-81.
38. ALOE L, TUVERI MA, LEVI-MONTALCINI R: Studies on carrageenan induced arthritis in adult rats: presence of nerve growth factor and role of sympathetic innervation. Rheumatol Int 1992; 12: 213-6.
39. HUKKANEN M, KONTTINEN YT, REES RG, GIBSON SJ, SANTAVIRTA S, POLAK JM: Innervation of bone from healthy and arthritic rats by substance P and CGRP containing sensory fibers. J Rheumatol 1992; 19: 1252-9.
40. HOPWOOD D: Fixation and fixatives. In: BANCROFT JD, STEVENS A (Eds.): Theory and Practice of Hisiological Techniques. Edinburg: Churchill Livingstone, 1982; 20-41.
41. JONSSON R, TARKOWSKY A, KLARESKOG L: A demineralisation procedure for immunohistopathological use. J Immunol Methods 1986; 88: 109-14.
42. COWEN T, HAVEN AJ, BURSTOCK G: Pontamine sky blue: a counterstain for background autofluorescence in fluorescence and immunofluorescence histochemistry. Histochemistry 1985: 82: 205-8.
43. BUNA P, VERSCHNEN C, VERSLEYEN D: CGRP, SP and GAP-43/B-50 immunoreactive nerves in the normal and arthrotic knee joint of the mouse. Histochemistry 1992; 98: 327-39.
44. RABINOWICZ T, JACQUELINE F: Pathology of the capsular and synovial hip nerves in chronic hip diseases. Pathol Res Pract 1990; 186: 283-92.
45. MAPP PI, WALSH DA, GARETT NE: Effect of three animal models of inflammation on nerve fiber in synovium. Ann Rheum Dis 1994; 53: 240-6.
46. AHMED M, BJURHOLM A, SCHULTZBERG M, THEODORSSON E, KREICBERGS A: Increased levels of substance P and calcitonin gene-related peptide in rat adjuvant arthritis. Arthritis Rheum 1995; 38: 699-709.
47. ALOE L, TUVERI MA, CARCASSI U, LEVI-MONTALCINI R: Nerve growth factor in the synovial fluid of patients with chronic arthritis. Arthritis Rheum 1992, 35: 351-5.
48. ALOE L, PROBERT L, KOLLIAS G, BRACCI-LAUDIERO L, SPILLANTIM MG, LEVI-MONTALCINI R: The synovium of transgenic arthritic mice expressing human tumor necrosis factor contains a high level of nerve growth factor. Growth Factors 1993; 9: 149-55.
49. HUKKANEN M, KONTTINEN YT, SANTAVIRTA S, PAAVOLAINEN P, GU XH. TERENGHI G, POLAK JM: Rapid proliferation of CGRP immunoreactive nerves during healing of rat tibial fracture suggests neural involvement in bone growth and remodelling. Neuroscience 1993; 54: 969-79.
50. MASI AT, FEIGENBAUM SL, KAPLAN SB: Articular patterns in the early course of rheumatoid arthritis. Am J Med 1983; 75 (Suppl. 6A): 16-26.
51. GULBENKIAN S, WHARTON J, POLAK JM: The visualisation of cardiovascular innervation in the guinea pig using an antiserum to protein gene product 9.5 (PGP 9.5). J Auton Nerv Syst 1987; 18: 235-47.
52. ABRAMOVICI A, DAIZADE I, YOSIPOVITCH Z, GIBSON SS, POLAK JM: The distribution of peptide-containing nerves in the synovia of the cat knee joint. Histol Histopathol 1991; 6: 469-76.
53. THIBAULT J, VIDAL D, GROSS F: In vitro translation of mRNA from rat phaeochromocytoma tumours, characterization of tyrosine hydroxylase. Biochem Res Comm 1981; 99: 960-8.
54. REHM H, WIEDENMANN B, BETZ H: Molecular characterization of synaptophysin, a major calcium-binding protein of the synaptic vesicle membrane. EMBO J 1986: 5: 535-41.
55. WHARTON J, GULBENKIAN S, MERJGHI A, ICUHN DM, JAHN R, TAYLOR KM, POLAK JM: Immunohistochemical and ultrastructural localization of peptide-containing nerves and myocardial cells in the human atrial appendage. Cell Tissue Res 1988; 254: 155-66.